Company Overview and News

 
Sanjay Tiwari new President of the The Sri Lanka Ceramics and Glass Council

2016-11-28 lankabusinessonline
(PRESS RELEASE) – Mr. Sanjay Tiwari, Managing Director & CEO,of Piramal Glass Ceylon PLC was elected as the new President of the Sri Lanka Ceramics and Glass Council at its 3th AGM held recently at the Cinnamon Grand Hotel, Colombo.

 
SLIIT Faculty of Business: Nurturing Industry Ready Professionals

2016-07-12 bizenglish.adaderana.lk
Commencing its operations as a department in 2007, the SLIIT Department of Business Management was upgraded to the Faculty of Business in 2012. It is the nurturing ground for about 1000 students at present. The faculty facilitates UGC approved BBA Special (Hons) Degree Program under the specialisations of Human Capital Management, Accounting and Finance, Marketing Management, Logistics and Supply Chain Management and Business Analytics.

 
SL delegation explores biz opportunities in South Africa, Zambia & Rwanda

2016-04-25 lankabusinessonline
A nine member Sri Lankan business delegation, led by the Ceylon Chamber of Commerce, recently visited South Africa, Zambia and Rwanda to explore commercial opportunities in those countries.

 
Dankotuwa Porcelain celebrates 33rd anniversary

2016-03-29 dailymirror.lk
Leading Sri Lankan porcelain manufacturer and exporter Dankotuwa Porcelain yesterday celebrated 33 years of operations. To mark the occasion, 33 trees were planted in the Dankotuwa Porcelain factory premises in Dankotuwa. The picture shows a factory employee ensuring the design dynamics of a tea cup before passing it to the next level in the manufacturing process PIC BY PRADEEP DILRUKSHANA

 
Dankotuwa Porcelain celebrates 33rd anniversary

2016-03-29 dailymirror.lk
Leading Sri Lankan porcelain manufacturer and exporter Dankotuwa Porcelain yesterday celebrated 33 years of operations. To mark the occasion, 33 trees were planted in the Dankotuwa Porcelain factory premises in Dankotuwa. The picture shows a factory employee ensuring the design dynamics of a tea cup before passing it to the next level in the manufacturing process PIC BY PRADEEP DILRUKSHANA

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

20h - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

20h - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...